Bicalutamide

Bicalutamide is a non-steroidal antiandrogen used in the treatment of prostate cancer. It blocks androgen receptors, preventing testosterone and dihydrotestosterone from stimulating cancer cell growth. Mediocon Inc supplies pharmaceutical-grade Bicalutamide meeting IP/BP/EP/USP standards.

Key Features

• Non-steroidal antiandrogen
• IP/BP/EP/USP compliant quality
• Prostate cancer treatment
• Suitable for oral tablet formulations

Applications

• Oral tablets for prostate cancer
• Hormone-sensitive cancer therapy
• Combination androgen deprivation therapy
• Oncology drug manufacturing

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings